3D Systems Expands Technology Leadership Team to Capitalize on & Accelerate Opportunities for Additive Manufacturing

An industry veteran, Dr. David Leigh, joins as Chief Technology Officer for Additive Manufacturing to drive innovation and innovation
Chuck Hull to increase focus on the success of regenerative medicine technology as Chief Technology Officer for Regenerative Medicine
ROCK HILL, S.C., June 28, 2021 (GLOBE NEWSWIRE) – 3D Systems (NYSE: DDD) today announced that it is expanding its senior leadership team focused on innovation with the addition of Chief Technology Officer Additive Manufacturing. Starting today, industry veteran Dr. David Leigh joins a company in this ability to accelerate and accelerate app development and product development that includes all Hardware, software, and building hardware solutions to add solutions.

With the arrival of Dr. Leigh, the founder of 3D Systems, Chuck Hull, will increase his emphasis on biotechnology as Chief Technology Officer for Regenerative Medicine, leading the development of solutions that create exciting new opportunities for regenerative medicine. According to Hull’s investigative team, which has now demonstrated the company’s partnership with United Therapeutics, a wide range of human applications, ranging from tissue implants, in addition to laboratory applications that accelerate the development of new therapies. Mr. Hull will also continue to support Government programs through the company’s large 3D printing press platform.

This expansion of technological leadership capacity directly reflects the rapid rate of acquisition of supplemental production in all health markets and industrial markets. This leadership focus will also revitalize the speed of 3D Systems for innovation, which is central to the company’s strategic goal as a leader in enabling additional production solutions for emerging market applications that require more reliable products. Dr. Leigh has more than 30 years of experience in the supplement manufacturing industry. Prior to joining 3D Systems, he worked as Chief Technology Officer (global) and Chief Operations Officer (North America) for EOS, a supplier of additional equipment. Dr. Leigh also founded Harvest Technologies which pioneered the use of end-to-end aerospace components and established one of the first certified production facilities for the AS9100. The harvest was won by Stratasys in 2014, during which time Dr. Leigh took over as the Vice President of Emerging Technology. He holds a Doctorate in Materials Science and Engineering, a Master of Science in Engineering, and a Bachelor of Science in Mechanical Engineering – all from the University of Texas in Austin, a pioneer doing university research in further manufacturing.An industry veteran, Dr. David Leigh, joins as Chief Technology Officer for Additive Manufacturing to drive innovation and innovation
Chuck Hull to increase focus on the success of regenerative medicine technology as Chief Technology Officer for Regenerative Medicine
ROCK HILL, S.C., June 28, 2021 (GLOBE NEWSWIRE) – 3D Systems (NYSE: DDD) today announced that it is expanding its senior leadership team focused on innovation with the addition of Chief Technology Officer Additive Manufacturing. Starting today, industry veteran Dr. David Leigh joins a company in this ability to accelerate and accelerate app development and product development that includes all Hardware, software, and building hardware solutions to add solutions.

With the arrival of Dr. Leigh, the founder of 3D Systems, Chuck Hull, will increase his emphasis on biotechnology as Chief Technology Officer for Regenerative Medicine, leading the development of solutions that create exciting new opportunities for regenerative medicine. According to Hull’s investigative team, which has now demonstrated the company’s partnership with United Therapeutics, a wide range of human applications, ranging from tissue implants, in addition to laboratory applications that accelerate the development of new therapies. Mr. Hull will also continue to support Government programs through the company’s large 3D printing press platform.

This expansion of technological leadership capacity directly reflects the rapid rate of acquisition of supplemental production in all health markets and industrial markets. This leadership focus will also revitalize the speed of 3D Systems for innovation, which is central to the company’s strategic goal as a leader in enabling additional production solutions for emerging market applications that require more reliable products.Dr. Leigh has more than 30 years of experience in the supplement manufacturing industry. Prior to joining 3D Systems, he worked as Chief Technology Officer (global) and Chief Operations Officer (North America) for EOS, a supplier of additional equipment. Dr. Leigh also founded Harvest Technologies which pioneered the use of end-to-end aerospace components and established one of the first certified production facilities for the AS9100. The harvest was won by Stratasys in 2014, during which time Dr. Leigh took over as the Vice President of Emerging Technology. He holds a Doctorate in Materials Science and Engineering, a Master of Science in Engineering, and a Bachelor of Science in Mechanical Engineering – all from the University of Texas in Austin, a pioneer doing university research in further manufacturing.

“Over the past year we have made great strides by focusing more on integrated production (AM) – reorganizing our business, reorganizing our operations, and separating non-AM assets,” said Dr. Jeffrey Graves, president & CEO, 3D Systems. “As we look to the future, with strong balance and fast cash flow we are accelerating our investment in people, systems, infrastructure and technologies that are conducive to growth and profitability. 3D Systems has tremendous potential to transform the industrial and healthcare markets by enabling the production of more measurable products, and bringing about new developments is essential to achieving our potential. We are very fortunate to have David and Chuck in these top leadership roles to drive application and technology development. In addition to their outstanding roles, both have demonstrated their ability to rethink processes, develop technologies, and create solutions that transform the way organizations work and deliver products and services to customers. David will be an outstanding asset to our leadership team and 3D Systems. He is a well-known leader in add-on technology with a track record of building efficient teams that drive innovation and product development. Chuck, who pioneered 3D printing, is now taking us to a new border of renewable medicine – a market that will transform our company and the world in the years to come. There has never been a better time in our company and in our industry. Forward Statements
Certain statements made in this publication that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include known and unknown risks, uncertainties and other factors that may result in actual results, performance or success of the company’s material differences in history or from any future results or assumptions expressed or implied by those forward-looking statements. In many cases, forward-looking statements can be identified by words such as “believe,” “belief,” “expect,” “may,” “may,” “estimate,” “intentional,” “expect” or “arrange” or the negative of these words or others. comparative terms. The forward-looking statements are based on management’s beliefs, assumptions, and current expectations and may include comments about the company’s beliefs and expectations regarding future events and trends affecting its business and subject to uncertainty, many of which are outside the Company’s control. The factors described under the headings “Forward Statements” and “Risk Factors” in the company’s periodic submissions by the Securities and Exchange Commission, among other things, may cause actual results to differ materially from those shown or predicted – visual statements. While management believes that the expectations expressed in the forward-looking statements are reasonable, the forward-looking statements do not exist, and should not be relied upon as a guarantee of performance or future results, nor will they in any way indicate that they are indicative of the times when such performance or results will be available. Submitted forward statements are only made from the date of the statement. 3D Systems does not make any obligation to update or update any forward-looking statements made by or on behalf of management, either as a result of future developments, subsequent events or conditions or otherwise.
Over the past 30 years, 3D Systems introduced 3D printing in the manufacturing industry. Today, as a leading partner in production solutions, we bring innovation, efficiency, and reliability across all communications – empowering our customers to create products and business models that have never existed before. Thanks to our unique offering of hardware, software, tools, and services, each application-specific solution is empowered by our app developers who work with customers to change the way they deliver their products and services. 3D Systems solutions address a wide range of high-quality applications in the healthcare and industries markets such as medical and dental, aerospace and defense, automotive and durable goods. More company information is available at”

Leave a Comment

Your email address will not be published. Required fields are marked *